Dr Reddys Laboratories Ltd.
5-Day | 179,405 |
10-Day | 117,171 |
30-Day | 87,213 |
5-Day | 179,405 |
10-Day | 117,171 |
30-Day | 87,213 |
Depth
Market Depth (24 Apr 2018)
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
3 | 2152.45 | 2166.95 | 1 |
10 | 2152.20 | 2167.00 | 10 |
57 | 2151.00 | 2167.20 | 120 |
19 | 2148.50 | 2168.00 | 88 |
10 | 2148.00 | 2170.00 | 31 |
2222 | Total | 2850 | Total |
Buy Qty
2222
Sell QTY
2850

5-Day | 331,296 |
10-Day | 388,867 |
30-Day | 392,397 |
5-Day | 331,296 |
10-Day | 388,867 |
30-Day | 392,397 |
- Quote
- CHARTS
- NEWS
- COMMENTS54 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
-
-
Announcements
USFDA issues Form 483 to Dr Reddy's Telengana unit -
Dr Reddys Labs
Sentimeter
89% of moneycontrol users recommend selling Dr Reddys Labs.
What's your call on Dr Reddys Labs today?
Read 54 investor views


Top Trading Ideas
24 April 2018
buy Lupin Apr Fut |
Entry Price (Rs) 809.00 |
Exit Price (Rs) 829.50 |
Gain (Rs) 21.00 |
buy ShriramTrans Apr Fut |
Entry Price (Rs) 1,634.00 |
Exit Price (Rs) 1,655.90 |
Gain (Rs) 22.00 |
buy Wockhardt Apr Fut |
Entry Price (Rs) 802.00 |
Exit Price (Rs) 817.00 |
Gain (Rs) 15.00 |
Days | BSE | NSE |
30 | 2120.04 | 2120.82 |
50 | 2143.87 | 2144.56 |
150 | 2282.67 | 2283.21 |
200 | 2297.13 | 2297.65 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs

Standalone | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
Net Sales | 2,501.30 | 2,246.20 | 2,078.50 | 2,303.40 |
Other Income | 47.70 | 40.40 | 48.80 | 59.50 |
PBDIT | 535.50 | 313.60 | 148.40 | 309.30 |
Net Profit | 296.90 | 100.70 | -7.30 | 223.00 |
(In Rs Cr)
Total Share Capital | 82.90 |
Net Worth | 11,600.60 |
Total Debt | 2,355.10 |
Net Block | 4,842.10 |
Investments | 3,101.90 |
Total Assets | 13,415.70 |
Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
Sun Pharma | 517.65 | 0.67 | 657.95 | 433.15 | 124,200.96 |
Cipla | 600.00 | 0.11 | 663.00 | 479.00 | 48,307.15 |
Piramal Enter | 2571.05 | -1.20 | 3064.86 | 2279.05 | 46,356.19 |
Cadila Health | 404.25 | 1.39 | 558.00 | 361.45 | 41,384.79 |
Biocon | 650.95 | 2.54 | 1044.40 | 294.97 | 39,057.00 |
More » |
Mar' 18 | Sep' 17 | Jun' 17 | Mar' 17 | |
Promoter | 30.87 | 31.43 | 31.94 | 32.04 |
Public (FII + DII) | 69.13 | 68.57 | 68.06 | 67.96 |
Others | 0.00 | 0.00 | 0.00 | 0.00 |
Total | 100.00 | 100.00 | 100.00 | 100.00 |
Scheme | No. of Shares |
Franklin India Prima Plus Fund (G) | 1,117,906 |
SBI - ETF Nifty 50 | 946,354 |
Aditya Birla Sun Life Frontline Equity Fund (G) | 883,172 |
Reliance Equity Opportunities Fund - Direct Plan (G) | 840,996 |
HDFC Bank Recommended on Jun 5th 2017
Recommended price 1,636.00 | Peak from reco 2014.00 23.12%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Dr Reddys Labs
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 35,778.66 crore.
The company management includes K Satish Reddy - Chairman, G V Prasad - Co-Chairman & Manag. Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Sridar Iyengar - Independent Director, Bharat N Doshi - Independent Director, Hans Peter Hasler - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills, Hyderabad,Telangana - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
